Which Is the Better Small-Cap ETF, Vanguard's VB or the iShares ISCB?

Vanguard Small-Cap ETF (VB) and iShares Morningstar Small-Cap ETF (ISCB) both offer low-cost small-cap exposure, with expense ratios of 0.03% and 0.04%, respectively. ISCB posted the stronger 1-year total return at 31.6% vs. 29.9% for VB, but VB has far larger assets under management at $182.7 billion versus $286.2 million and a slightly lower beta of 1.04. The article frames VB as the better long-term hold due to liquidity and cost, while ISCB offers broader diversification and a slightly higher dividend yield of 1.3%.

Analysis

The real signal here is not “small caps are good,” but that the cheapest/liquidest wrapper is increasingly acting as a volatility sink for the asset class. VB’s scale and tighter trading conditions make it the default vehicle for systematic allocators and adviser model portfolios, which should keep flows biased toward the larger product even if the marginal index construction advantage belongs to the broader basket. That matters because small-cap leadership tends to be flow-sensitive; when passive and model money concentrate in one fund, the underlying names in that basket can get a persistent liquidity bid that outlasts the headline factor rotation.

Within holdings, the most interesting second-order effect is that the higher industrial and tech weights in VB create a cleaner lever to domestic capex and AI-related supply chain spend than a generic small-cap beta trade. FLEX, CIEN, and ALAB are the types of names that can re-rate if the market starts rewarding “real economy pick-and-shovel” exposure over mega-cap concentration. Conversely, a broader basket like ISCB dilutes upside from the strongest secular winners and behaves more like a pure risk premia vehicle, which can lag in a tape where investors want a few identifiable growth winners rather than 1,500 names of mediocre quality.

The risk case is that the current strong 12-month numbers are backward-looking and vulnerable to a sharp repricing if rates back up or credit spreads widen. Small caps typically trade less on earnings revisions than on financing conditions; if the market starts to price slower cuts or sticky inflation, the group can give back a meaningful portion of the recent outperformance within weeks, not quarters. In that regime, the slightly lower beta and far better liquidity of VB should hold up better than ISCB, but both remain exposed to a classic small-cap funding squeeze.

Consensus is probably underestimating how much this is a dispersion trade rather than a simple asset-allocation trade. The better expression is not “buy small caps,” but “own the high-quality, industrial/tech-adjacent small-cap winners and avoid the broadest basket if you want alpha.” ISCB’s broader diversification reduces idiosyncratic blowups, but it also caps upside because the market’s scarce-growth premium is likely to cluster in a handful of names.

Key Decisions for Investors

• Long VB / short ISCB for 1-3 months: express a preference for liquidity and tighter trading while keeping similar factor exposure; target a modest spread capture if flows continue to favor the larger, cheaper wrapper.
• Buy ALAB or FLEX on a 2-6 week pullback as a higher-beta small-cap capex proxy; upside is a re-rating if industrial technology spending remains resilient, with downside limited by their stronger relative business quality versus the basket.
• Pair long VB vs short IWM if rates stay sticky: VB’s slightly lower beta and superior liquidity should make it the more defensive small-cap exposure while still participating in the group.
• Use a small allocation to ISCB only as a diversification sleeve, not a return driver; the risk/reward is better for investors who need broad exposure but should expect lagging upside versus a concentrated small-cap quality basket.
• Set a tactical stop on small-cap longs if 10Y yields break higher: that is the cleanest macro catalyst to unwind the recent outperformance and could hit the group within days to weeks.